Systemic and Dermatologic Impact of Mpox: An Overview of Guideline-Based Management for Nigerian Healthcare Workers https://doi.org/10.60787/NMJ-64-1-142
Main Article Content
Keywords
Dermatology, MPox, Monkeypox, Skin Health Advisory
Abstract
Monkeypox/Mpox is an Orthopoxvirus infection of the skin and mucous membranes in the same family as smallpox virus. Infection mainly affects the skin, but the eyes, lungs, brain, gastrointestinal tract, and other organs may also be involved to varying degrees. This narrative review on the systematic and dermatologic impact of Mpox is meant for healthcare workers, providers of social services, community leaders, religious leaders, staff of schools, influencers, and institutions. This is in a bid to bring them up to date with the clinical protocol involved in the diagnosis, management, and prevention of the spread of Mpox.
Data and other pieces of information used in this review were accessed from PubMed, Google Scholar, and situation reports from the website of the Nigerian Centre for Disease Control (NCDC), the World Health Organization (WHO), and the Centre for Disease Control and Prevention (CDC). The search date was from 1980 to May 2022. Prompt recognition and diagnosis were found to be predicated on a high index of clinical suspicion while diagnosis can be confirmed through viral DNA polymerase chain reaction tests.
The management of Mpox involves a multidisciplinary approach with Dermatologists playing a central role alongside other specialists and experts as it affects diagnosis, management, and follow-up. The Government should provide an enabling environment for surveillance, notification, and research of this global infection. Since the clinical presentation of Mpox is regularly changing, a regular review of the available guidelines is recommended
References
2.Yinka-Ogunleye A, Aruna O, Dalhat M, Ogoina D, McCollum A, Disu Y, et al. Outbreak of human Monkeypox in Nigeria in 2017-18: a clinical and epidemiological report. Lancet Infect. Dis.2019; 19:872–879.
3.Nigerian Centre for Disease Control. National Monkeypox public health response guideline, 2019. [cited 2022 April 3] Available from: https://ncdc.gov.ng/themes/common/docs/protocols/96_1577798337.pdf.
4.Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution.Viruses. 2020; 12:1257.doi: 10.3390/v12111257
5.Rimoin AW, Mulembakani PM, Johnston SC, Lloyd Smith JO, Kisalu NK, Kinkela TL, et al. Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo. Proc. Natl. Acad. Sci. U S A. 2010; 107:16262–16267.
6.Grant R, Nguyen LL, Breban R. Modelling human-to-human transmission of monkeypox. Bull. World Health Organ. 2020; 98:638–640.
7.Jezek Z, Gromyko AI, Szczeniowski MV. Human monkeypox. J Hyg Epidemiol Microbiol Immunol. 1983; 27:13-28.
8.Gani R,Leach S.Transmission potential of smallpox in contemporary populations.Nature. 2001; 414:748–751. 10.1038/414748a
9.World Health organization. WHO Director-General's statement at the press conference following IHR Emergency Committee regarding the multi-country outbreak of monkeypox. [posted 23 July 2022] [cited 2022 August 11] Available from:https://www.who.int/director-general/speeches/detail/who-director-general-s-statement-on-the-press-conference-following-IHR-emergency-committee-regarding-the-multi--country-outbreak-of-Mpox--23-july-2022.
10.World Health Organization, Europe. WHO Director-General declares the ongoing Monkeypox outbreak a public health emergency of international concern. Available from:https://www.who.int/europe/news/item/23-07-2022-who-director-general-declares-the-ongoing-monkeypox-outbreak-a-public-health-event-of-international-concern
11.World Health Organization. Clinical management and infection prevention and control for monkeypox: interim rapid response guidance. [posted 2022June 10] [cited 2022 July 6] Available from:WHO-MPX-Clinical_and_IPC-2022.1-eng.pdffile:///C:/Users/Surfaces/Desktop/MONKEYPOX%20IN%20NIGERIA/WHO-MPX-Clinical_and_IPC-2022.1-eng.pdf.
12.Khodakevich L, Jezek Z, Kinzanzka K. Isolation of monkeypox virus from wild squirrel infected in nature. Lancet.1986; 1:98–99.
13.Radonić A, Metzger S, Dabrowski PW, Couacy-Hymann E, Schuenadel L, Kurth A, et al. Fatal monkeypox in wild-living sooty mangabey, Côte d'Ivoire, 2012. Emerg. Infect.Dis.2014; 20:1009–1011.
14.World Health Organization fact sheet. Monkeypox. [cited 2022 August 11] Available from: https://www.who.int/news-room/fact-sheets/detail/monkeypox
15.Nigeria Centre for Disease Control. An update on the monkeypox outbreak in Nigeria (internet). [cited 2022 August 11] Available from: file:///C:/Users/Surfaces/Desktop/MPX%20WORKS%20BY%20SEBOIWOH/An%20Update%20of%20Mpox%20Outbreak%20in%20Nigeria_210722_30%20(1).pdf.
16.Centre for disease control and prevention. Interim clinical guidance for the treatment of Mpox. [posted 2022 July 28] Available from: https://www.cdc.gov/poxvirus/Mpox/clinicians/treatment.html
17.Levine JM. Skin Failure: An Emerging Concept. J Am Med Dir Assoc. 2016;17: 666-669.
18.Fuchs E. Epithelial Skin Biology: Three Decades of Developmental Biology, a Hundred Questions Answered and a Thousand New Ones to Address. Cure Top Dev Biol. 2016116:357-374.
19.Ogoina D, Iroezindu M, James HI, Oladokun R, Yinka-Ogunleye A, Wakama P, et al. Clinical course and outcome of human monkeypox in Nigeria.Clin. Infect. Dis.2020; 71:e210–e214.
20.Echekwube P, Mbaave P, Abidakun O, Utoo B, Swende T. Human monkeypox and human immunodeficiency virus co-infection: a case series in Makurdi, Benue State, Nigeria. J. Biomed. Res. Clin. Pract.2020; 3:375–381.
21.Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, et al. Monkeypox Virus Infection in Humans across 16 Countries -April-June 2022. N Engl J Med. 2022; 387:679-691.
22.Graham M.B. Monkeypox/Mpox clinical presentation. https://emedicine.medscape.com/article/1134714-clinical. Accessed September 2022.
23.Osadebe L, Hughes CM, Shongo Lushima R, Kabamba J, Nguete B, Malekani J, et al. Enhancing case definitions for surveillance of human monkeypox in the Democratic Republic of Congo. PLoS Negl Trop Dis. 2017 Sep 11; 11:e0005857. DOI: 10.1371/journal.pntd.0005857.
24.Macneil A, Reynolds MG, Braden Z, Carroll DS, Bostik V, Karem K, Smith SK, Davidson W, Li Y, Moundeli A, Mombouli JV, Jumaan AO, Schmid DS, Regnery RL, Damon IK. Transmission of atypical varicella-zoster virus infections involving palm and sole manifestations in an area with monkeypox endemicity. Clin Infect Dis.2009 Jan 1; 48:e6-8. DOI: 10.1086/59555225.World Health Organization. Monkeypox. https://www.who.int/news-room/fact-sheets/detail/monkeypox. Accessed September 19, 2022.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open-access journal and articles are distributed under the terms of the Creative Commons Attribution Non-Commercial Share-Alike License 4.0. This licence allows users to download and share, remix, tweak and build upon the article for non-commercial purposes, so long as the original authorship is acknowledged and the new creations are licensed under identical terms.